|
Proceedings
Day 3 - Thursday, October 10, 2002
ThOA
Data Management in a High-throughput Analysis Environment
Discussion Leader: Randall K. Julian, Eli Lilly & Company
Data Management in High-Throughput Mass Spectrometry I:
Automating Library and Result Processing Tasks
Eric B. Stauffer, Eli Lilly & Company
Data Management in High-Throughput Mass Spectrometry II:
Automated Spectral Analysis
Randall K. Julian, Eli Lilly & Company
Integration of Data Production, Processing
and Visualization to Support High Throughput analysis of Intact Proteins
Greg Taylor, University of Illinois
Roundtable Discussion 7
ThOB
Why Does Method Development Take So Long?
Discussion Leader: Roger N. Hayes, Schering-Plough Reserach institute
The Changing Functionality of Pharmaceutical Compund Repositories
Brett Monia, ISIS Pharmaceuticals
Accelerating Method Development Using an Automated Modular Strategy and On-Line Turbulent Flow Chromatography
Russell Grant, Eli Lilly Canada, Inc.
Factors Effecting the Performance of Solid Phase Extraction in Conjunction with LC-MS/MS Analysis
Kenneth D. Roth, Schering-Plough Research Institute
High-Throughput Assay Validation in a GLP Laboratory
Preston P. Davis, Schering-Plough Research Institute
Roundtable Discussion 8
Poster Session Reviews
Discussion Leaders: Neil Loftus, Shimadzu Biotech, and Eric Solon, Quest Pharmaceutical Services
ThOC
In-Source, Out-Source: What Do Pharmaceutical Companies Do for Bioanalytical Support?
Discussion Leader: Voon Ong, Memory Pharmaceuticals
Zamas Lam, Quest Pharmaceutical Services
Peter L. Bullock, Purdue Pharma
Tanya R. Myers, Solvay Pharmaceuticals
Roundtable Discussion 9
ThOD
Crystal City Guideline Review
Discussion Leader: Tom Huggins, Proctor & Gamble Pharmaceuticals
Al Yergey, National Institutes of Health
Bob Nicholson, PPD Development
Charles Grandmaison, MDS Pharma
Min Chang, Abbott Laboratories
Danlin Wu, Purdue Pharma
Wrap-Up
Kenneth L. Morand, Proctor & Gamble Pharmaceuticals
|